All Stories

  1. In silico study to evaluate the antiviral activity of novel structures against 3C-like protease of Novel Coronavirus (COVID-19) and SARS-CoV
  2. Neprilysin, the kidney brush border neutral proteinase: a possible potential target for ischemic renal injury